EUVIMEDEUVIMED entdecken
Crossref

Combinatorial Screening of Biscarbamate Ionizable Lipids Identifies a Low Reactogenicity Lipid for Lipid Nanoparticle mRNA Delivery

Emily De Lombaerde, Yong Chen, Tingting Ye, Julie Deckers, Giulia Mencarelli, Kim De Swarte, Heleen Lauwers, Ruben De Coen, Sabah Kasmi, Sanne Bevers, Anna Kuchmiy, Bram Bogaert und 8 weitere

Advanced Functional Materials · 2024-05 · 34 (21)

DOI: 10.1002/adfm.202310623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, 2024-02. Verfasst von Emily De Lombaerde und 19 weiteren Autor:innen. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: H2020 European Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) has emerged as a promising therapeutic modality for various diseases. However, efficient delivery of mRNA into target cells remains a significant challenge. In this study, the combinatorial synthesis and characterization of a novel series of ionizable biscarbamate lipids (IBLs) for mRNA lipid nanoparticle (LNP) delivery are reported. A simplified and scalable method is developed, resulting in IBLs suitable for formulating mRNA into stable LNPs. Two generations of IBLs are synthesized and evaluated for their mRNA transfection capacity in vitro, using eGFP as a reporter protein, leading to the identification of S‐Ac7‐DOG as a lead IBL. Upon intramuscular vaccination, S‐Ac7‐DOG LNPs instigated robust antigen‐specific CD8+ T cell responses against an mRNA encoded viral oncoprotein and a tumor neo‐antigen. In comparison to MC3 LNPs, which are used as a benchmark, S‐Ac7‐DOG LNPs exhibit low reactogenicity, robust mRNA transfection, and a distinct biodistribution, with higher accumulation in draining lymph nodes and spleen. These findings highlight the potential of IBLs as a novel and promising class of ionizable lipids for mRNA delivery in vaccines and beyond.

Förderung

  • H2020 European Research Council

Zitieren

APA

Lombaerde, E. D., Chen, Y., Ye, T., Deckers, J., Mencarelli, G., Swarte, K. D., Lauwers, H., Coen, R. D., Kasmi, S., Bevers, S., Kuchmiy, A., Bogaert, B., Baekens, L., Zhong, Z., Lamoot, A., Sanders, N. N., Lambrecht, B. N., Baptista, A. P., Koker, S. D., & Geest, B. G. D. (2024). Combinatorial Screening of Biscarbamate Ionizable Lipids Identifies a Low Reactogenicity Lipid for Lipid Nanoparticle mRNA Delivery. Advanced Functional Materials, 34(21). https://doi.org/10.1002/adfm.202310623

Vancouver

Lombaerde ED, Chen Y, Ye T, Deckers J, Mencarelli G, Swarte KD, et al. Combinatorial Screening of Biscarbamate Ionizable Lipids Identifies a Low Reactogenicity Lipid for Lipid Nanoparticle mRNA Delivery. Advanced Functional Materials. 2024;34(21). doi:10.1002/adfm.202310623

BibTeX
@article{Lombaerde2024,
  author = {Lombaerde, Emily De and Chen, Yong and Ye, Tingting and Deckers, Julie and Mencarelli, Giulia and Swarte, Kim De and Lauwers, Heleen and Coen, Ruben De and Kasmi, Sabah and Bevers, Sanne and Kuchmiy, Anna and Bogaert, Bram and Baekens, Lies and Zhong, Zifu and Lamoot, Alexander and Sanders, Niek N. and Lambrecht, Bart N. and Baptista, Antonio P. and Koker, Stefaan De and Geest, Bruno G. De},
  title = {Combinatorial Screening of Biscarbamate Ionizable Lipids Identifies a Low Reactogenicity Lipid for Lipid Nanoparticle mRNA Delivery},
  journal = {Advanced Functional Materials},
  year = {2024},
  volume = {34},
  number = {21},
  doi = {10.1002/adfm.202310623}
}
Kostenlos starten →